Orka Two vs Yeasound RIC800

The Orka Two is a behind-the-ear prescription hearing aid priced at $1,899, earning an A grade with a SoundScore of 4.0/5 in our lab testing. This places it in the top 67% of the 36 prescription hearing aids we've evaluated, ranking #25 in its category. In our testing, the Orka Two shows a mixed performance profile with clear strengths and weaknesses. Music streaming stands out at 3.3/5, measuring 0.66 points above the category average—a solid result for users who prioritize phone audio quality. Own-voice comfort also performs well at 3.2/5, sitting 0.45 points above average, which may contribute to a more natural listening experience. Feedback handling is excellent at 5.0/5, among the best we've measured. However, speech-in-noise performance is a notable limitation. At 1.4/5, it falls 0.56 points below the category average—a low absolute score that may affect understanding in challenging listening environments like restaurants or group conversations. Speech in quiet fares better at 3.7/5, measuring 0.40 points above average. The Orka Two may suit users who prioritize streaming quality, own-voice comfort, and stability over speech-in-noise performance. Those frequently in noisy environments should note that competitors in this price range, such as the Rexton Reach R-Li T80 at Costco (4.58/5), deliver stronger overall scores. Budget-conscious shoppers might also consider lower-priced alternatives like the Sony CRE-C10, which scored 4.19/5 in our testing.

The Yeasound RIC800 is a mid-priced OTC hearing aid that earned an A grade with a SoundScore of 4.8/5 in our lab testing, placing it #2 among 65 OTC devices tested. At $659, this behind-the-ear rechargeable device delivers performance that significantly outpaces the category average of 3.71/5. Speech clarity is a standout strength. The RIC800 scores 4.4/5 for speech in quiet—a strong result that sits 1.63 points above the OTC category average. Speech in noise performance is more mixed at 2.4/5, though this still lands 0.93 points above the typical OTC device. Music streaming is where this device truly excels, scoring 4.3/5 and outperforming the category average by a substantial 2.38 points—making it one of the better choices for consumers who frequently stream audio from their phone. Feedback handling is excellent at 5.0/5, meaning users shouldn't encounter whistling issues during normal wear. The tradeoff comes with own-voice comfort, which scores 2.1/5—a mixed result that falls 0.41 points below the category average. Some users may notice their own voice sounds more hollow or boomy than expected. The RIC800 earned a 2025 Expert's Choice Award and supports both iPhone and Android streaming. For consumers seeking strong speech performance and exceptional streaming quality in the OTC space, this device represents a compelling option. Those particularly sensitive to own-voice quality may want to compare alternatives, but overall performance places the RIC800 among the top tier of OTC hearing aids we've tested.